We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GAO: Progress in FDA’s Overseas Inspections Still Hurt by Vacancies
GAO: Progress in FDA’s Overseas Inspections Still Hurt by Vacancies
The FDA has made great strides in conducting international inspections — but still remains detrimentally understaffed, according to the government’s official watchdog, during a time when the agency has begun to inspect more sites overseas than within the U.S.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor